Flagellin engineering enhances CAR-T cell function by reshaping tumor microenvironment in solid tumors
Background
Adoptive cell therapy using genetically engineered chimeric antigen receptor (CAR)-T cells is a new type of immunotherapy that directs T cells to target cancer specifically. Although CAR-T therapy has achieved significant clinical efficacy …